These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20050100)

  • 21. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y; Arnott W
    J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
    Doumas M; Tsakiris A; Douma S; Grigorakis A; Papadopoulos A; Hounta A; Tsiodras S; Dimitriou D; Giamarellou H
    Asian J Androl; 2006 Mar; 8(2):177-82. PubMed ID: 16491268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
    Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
    Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with the superselective third-generation beta-adrenoblocker nebivolol used to treat patients with prior myocardial infarction].
    Bichan NA; Bykova EF; Gorbatovskiĭ IaA; Pakhtusova NI; Mishchenko EP; Onishchenko EG
    Klin Med (Mosk); 2004; 82(8):57-60. PubMed ID: 15468728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and antihypertensive effect with nebivolol and losartan.
    Van Bortel LM; Bulpitt CJ; Fici F
    Am J Hypertens; 2005 Aug; 18(8):1060-6. PubMed ID: 16296572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study.
    Van Bortel LM
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):749-58. PubMed ID: 21061833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension.
    Peter P; Martin U; Sharma A; Dunne F
    J Clin Pharm Ther; 2006 Apr; 31(2):153-9. PubMed ID: 16635049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
    Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Administration of cardioselective beta-adrenoblockers in patients with arterial hypertension and/or ischemic heart disease associated with bronchoobstructive syndrome].
    Ovcharenko SI; Litvinova IV; Mikolkin VI
    Ter Arkh; 2007; 79(9):12-8. PubMed ID: 18038580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.